期刊文献+

食管鳞状细胞癌外周血单个核细胞Th1/Th2漂移的临床意义 被引量:1

Significance of Th1/Th2 shift in PBMC of patients with esophageal squamous cell cancer
下载PDF
导出
摘要 目的:探讨外周血单个核细胞(PBMC)Th1、Th2类细胞因子的表达与食管鳞状细胞癌病理因素之间的相关性。方法:采用双抗体酶联免疫吸附法(ELISA)检测39例食管鳞状细胞癌患者外周血Th1、Th2类细胞因子的含量水平,并与食管鳞状细胞癌病理因素之间进行相关分析。结果:食管鳞状细胞癌患者PBMC中,IL-2、INF-γ的表达明显低于健康对照组,P<0·05;IL-6的表达明显高于对照组,P<0·05,存在Th1/Th2漂移现象。且发现TNM分期越晚,Th1类细胞因子IL-2的表达越弱,而IL-6表达越强,差异有统计学意义,P<0·05。Th1/Th2漂移现象与肿瘤分化程度无明显相关性。结论:食管鳞状细胞癌患者PBMC存在Th2细胞优势,而Th1类细胞因子表达减弱;Th1/Th2漂移现象与肿瘤的TNM分期有关。 OBJECTIVE: To study the relationship mononualear cell between the expression of Thl Th2 type cytokincs of peripheral blood and its pathological factors in the patients with esophageal squamous cell cancer. METHODS: Enzyme linked immunosorbent assay (ELISA) was used to detect the expressions of Thl (IL-2 and INF-γ) and Th2 (IL-4,IL-6 and IL-10) type cytokines in and thciv signi fi cances 39 patients with esophageal squamous cell carcinoma. RESULT: Th1 Th2 shift existed in the patients with esophageal squamous cell cancer, levels of Th1 type cytokincs were significantly lower in the patients with esophageal squamous cell cancer than those in the control group, hut Th2 type cytokines (IL-6) was on the contrary. In the advanced patients with esophageal squamous cell cancer, the level of Thl type cytokines (especially IL-2) deeply decreased, but IL-6 was much increased. P〈0.05. Levels of Th1 and Th2 type cytokincs did not show relation with tumor differentiation. CONCLUSION: The level of Th1 type cytokines weakens that of in PBMC of patients with esophageal squamous cell cancer, lint Th2 type cytnkines enhances. The Th1 Th2 shift is associated with TNM stage in patients with esophageal squamnus cell cancer, hut show no relation with tumor differentiation.
出处 《肿瘤防治杂志》 2005年第18期1382-1384,共3页 China Journal of Cancer Prevention and Treatment
关键词 食管肿瘤 鳞状细胞 血清 TH1/TH2漂移 esophagea neoplasms carcinoma, squanous cell serum Th1 Th2 shift
  • 相关文献

参考文献7

  • 1Abbas A K, Murphy K M, Sher A. Functional diversity of helper T lymphocytes[J]. Nature, 1996,383(6603):787-793.
  • 2Romagnani S. Lymphokine production by human T cells in disease states[J]. Annu Rev Immunol, 1994,12 : 227- 257.
  • 3Kavanaugh V, Carbone D P. Immunologic dysfunction in cancer [J]. Hematol Oncol Clin North Am, 1996, 10(4):927-951.
  • 4Maraskovsky E, Chen W F, Shortman K. IL-2 and IFN-γ are two necessary lymphokines in the development of cytolytic T cells[J]. J Immunol, 1989, 143(4) :1210-1214.
  • 5Zhang X L, Yoshihiro K, James C. Intracellar cytokine profile of T cells from children with acute lymphoblastic leukemia[J].Cancer Immunol Immunother, 2000, 49(3): 165- 172.
  • 6Picher L J, Singh M K, Zdraveski Z. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry[J]. Blood, 1995, 86(4) : 1408-1419.
  • 7Ammamura M, Modlin R L, Ohmen J D, et al. Local expression of anti-inflammatory cytokines in cancer[J]. J Clin Invest,1993,91(3) :1005-1011.

同被引文献6

  • 1王军业,戴淑琴,叶文锋,龙浩,林鹏,李宝江,戎铁华.联合检测外周血T淋巴细胞AgNOR活性及T淋巴细胞亚群评估食管癌围手术期细胞免疫变化规律[J].癌症,2005,24(7):861-864. 被引量:8
  • 2Ichihara F,Kono K,Takahashi A,et al.Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers[J].Clin Cancer Res,2003,9(12):4404-4408.
  • 3Watanabe H,Kato H,Tachimori Y,et al.Significance of extended systemic lymph node dissection for thoracic esophageal carcinoma in Japan[J].Recent results Cancer Res,2000,155:123-133.
  • 4Rasi G,Terzoli E,Izzo F,et al.Combined treatment with thymosin a l and low-dose interferon alpha after dacarbazine in advanced melanoma[J].Melanoma Res,2000,10(2):189-192.
  • 5Andreone P,Cursaro C,Gramenzi A,et al.In vitro effect of thymosin-alphal and interferon-alpha on Thl and Th2 cytokine syn thesis in patients with chronic hepatitis C[J].J Viral Hepatitis,2001,8(3):194-201.
  • 6王军业,戎铁华,梁伊仁,龙浩,陈巧伦,马国伟.外周血T淋巴细胞AgNOR检测在食管癌诊断中的应用[J].癌症,2004,23(5):577-580. 被引量:10

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部